212 related articles for article (PubMed ID: 36174106)
21. Essential role of Rta in lytic DNA replication of Epstein-Barr virus.
El-Guindy A; Ghiassi-Nejad M; Golden S; Delecluse HJ; Miller G
J Virol; 2013 Jan; 87(1):208-23. PubMed ID: 23077295
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus.
Lu CC; Jeng YY; Tsai CH; Liu MY; Yeh SW; Hsu TY; Chen MR
Virology; 2006 Feb; 345(2):358-72. PubMed ID: 16298410
[TBL] [Abstract][Full Text] [Related]
23. The Epstein-Barr virus LF2 protein inhibits viral replication.
Calderwood MA; Holthaus AM; Johannsen E
J Virol; 2008 Sep; 82(17):8509-19. PubMed ID: 18562535
[TBL] [Abstract][Full Text] [Related]
24. X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.
Lai IY; Farrell PJ; Kellam P
J Gen Virol; 2011 Feb; 92(Pt 2):421-31. PubMed ID: 20980528
[TBL] [Abstract][Full Text] [Related]
25. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
Flemington EK; Lytle JP; Cayrol C; Borras AM; Speck SH
Mol Cell Biol; 1994 May; 14(5):3041-52. PubMed ID: 8164660
[TBL] [Abstract][Full Text] [Related]
26. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
Cox MA; Leahy J; Hardwick JM
J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
[TBL] [Abstract][Full Text] [Related]
27. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors.
Chen C; Li D; Guo N
Cancer Biol Ther; 2009 Jun; 8(11):987-95. PubMed ID: 19448399
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
30. Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus.
Chen LW; Chang PJ; Delecluse HJ; Miller G
J Virol; 2005 Aug; 79(15):9635-50. PubMed ID: 16014926
[TBL] [Abstract][Full Text] [Related]
31. Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.
Huang J; Liao G; Chen H; Wu FY; Hutt-Fletcher L; Hayward GS; Hayward SD
J Virol; 2006 Feb; 80(3):1098-109. PubMed ID: 16414987
[TBL] [Abstract][Full Text] [Related]
32. Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain.
Wang P; Day L; Lieberman PM
J Virol; 2006 Nov; 80(22):10942-9. PubMed ID: 16971443
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
34. Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus.
Chang PJ; Chang YS; Liu ST
J Virol; 1998 Jun; 72(6):5128-36. PubMed ID: 9573284
[TBL] [Abstract][Full Text] [Related]
35. Expression and regulation of the BKRF2, BKRF3 and BKRF4 genes of Epstein-Barr virus.
Chen LW; Hung CH; Wang SS; Yen JB; Liu AC; Hung YH; Chang PJ
Virus Res; 2018 Sep; 256():76-89. PubMed ID: 30096410
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.
Tung CP; Chang FR; Wu YC; Chuang DW; Hunyadi A; Liu ST
J Gen Virol; 2011 Aug; 92(Pt 8):1760-1768. PubMed ID: 21490247
[TBL] [Abstract][Full Text] [Related]
37. Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.
Balan N; Osborn K; Sinclair AJ
J Gen Virol; 2016 Mar; 97(3):725-732. PubMed ID: 26653871
[TBL] [Abstract][Full Text] [Related]
38. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
[TBL] [Abstract][Full Text] [Related]
39. Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation.
Wang P; Rennekamp AJ; Yuan Y; Lieberman PM
J Virol; 2009 Aug; 83(16):8090-8. PubMed ID: 19494003
[TBL] [Abstract][Full Text] [Related]
40. Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1.
Chang LK; Chung JY; Hong YR; Ichimura T; Nakao M; Liu ST
Nucleic Acids Res; 2005; 33(20):6528-39. PubMed ID: 16314315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
